ALBO - Albireo Pharma EPS beats by $2.41 misses on revenue November, 04 2021 08:36 AM Albireo Pharma Inc. Albireo Pharma (NASDAQ:ALBO): Q3 GAAP EPS of $2.90 beats by $2.41. Revenue of $3.67M (+72.3% Y/Y) misses by $13.38M. Press Release For further details see: Albireo Pharma EPS beats by $2.41, misses on revenue